130 related articles for article (PubMed ID: 33104018)
1. Overexpression of FADD and Bcl-XS proteins as novel prognostic biomarkers for surgically resected non-small cell lung cancer.
Chen L; Xie G; Feng J; Wen Q; Zang H; Lu J; Zhan Y; Fan S
Cancer Biomark; 2021; 30(2):145-154. PubMed ID: 33104018
[TBL] [Abstract][Full Text] [Related]
2. Elevated expression of mcl-1 inhibits apoptosis and predicts poor prognosis in patients with surgically resected non-small cell lung cancer.
Wen Q; Zhan Y; Zheng H; Zang H; Luo J; Zhang Y; Wang W; Feng J; Lu J; Chen L; Fan S
Diagn Pathol; 2019 Oct; 14(1):108. PubMed ID: 31601252
[TBL] [Abstract][Full Text] [Related]
3. Clinical significance of PD
Lu J; Feng J; Zheng H; Wen Q; Fan S
Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2020 Oct; 45(10):1149-1154. PubMed ID: 33268574
[TBL] [Abstract][Full Text] [Related]
4. Expression of DR5 and c‑FLIP proteins as novel prognostic biomarkers for non‑small cell lung cancer patients treated with surgical resection and chemotherapy.
Zheng H; Zhang Y; Zhan Y; Liu S; Lu J; Wen Q; Fan S
Oncol Rep; 2019 Dec; 42(6):2363-2370. PubMed ID: 31638235
[TBL] [Abstract][Full Text] [Related]
5. Prognostic evaluation of the expression of p53 and bcl-2 oncoproteins in patients with surgically resected non-small cell lung cancer.
Lai RS; Wang JS; Hsu HK; Chang HC; Lin CH; Lin MH
Jpn J Clin Oncol; 2002 Oct; 32(10):393-7. PubMed ID: 12451034
[TBL] [Abstract][Full Text] [Related]
6. Prognostic significance of tumor poliovirus receptor and CTLA4 expression in patients with surgically resected non-small-cell lung cancer.
You H; Zhang YZ; Lai HL; Li D; Liu YQ; Li RZ; Khan I; Hsiao WW; Duan FG; Fan XX; Yao XJ; Cao YB; Wu QB; Leung EL; Wang MF
J Cancer Res Clin Oncol; 2020 Jun; 146(6):1441-1450. PubMed ID: 32248302
[TBL] [Abstract][Full Text] [Related]
7. FADD protein release mirrors the development and aggressiveness of human non-small cell lung cancer.
Cimino Y; Costes A; Damotte D; Validire P; Mistou S; Cagnard N; Alifano M; Régnard JF; Chiocchia G; Sautès-Fridman C; Tourneur L
Br J Cancer; 2012 Jun; 106(12):1989-96. PubMed ID: 22669160
[TBL] [Abstract][Full Text] [Related]
8. Immunohistochemical demonstration of apoptosis-regulated proteins, Bcl-2 and Bax, in resected non-small-cell lung cancers.
Hanaoka T; Nakayama J; Haniuda M; Sato TA
Int J Clin Oncol; 2002 Jun; 7(3):152-8. PubMed ID: 12109516
[TBL] [Abstract][Full Text] [Related]
9. Elevated expression of G3BP1 associates with YB1 and p-AKT and predicts poor prognosis in nonsmall cell lung cancer patients after surgical resection.
Zheng H; Zhan Y; Zhang Y; Liu S; Lu J; Yang Y; Wen Q; Fan S
Cancer Med; 2019 Nov; 8(16):6894-6903. PubMed ID: 31560169
[TBL] [Abstract][Full Text] [Related]
10. Overexpression of p-Akt, p-mTOR and p-eIF4E proteins associates with metastasis and unfavorable prognosis in non-small cell lung cancer.
Lu J; Zang H; Zheng H; Zhan Y; Yang Y; Zhang Y; Liu S; Feng J; Wen Q; Long M; Fan S
PLoS One; 2020; 15(2):e0227768. PubMed ID: 32023262
[TBL] [Abstract][Full Text] [Related]
11. [Expression and mutation of Fas-associated death domain (FADD) gene in non-small cell lung cancer].
Yang Q; Zhu RQ; Fang Z; Xia D; Diao LM; Liu MQ
Ai Zheng; 2005 Mar; 24(3):321-6. PubMed ID: 15757534
[TBL] [Abstract][Full Text] [Related]
12. Impact of PD-L1 Expression in Patients with Surgically Resected Non-Small-Cell Lung Cancer.
Igawa S; Sato Y; Ryuge S; Ichinoe M; Katono K; Hiyoshi Y; Otani S; Nagashio R; Nakashima H; Katagiri M; Sasaki J; Murakumo Y; Satoh Y; Masuda N
Oncology; 2017; 92(5):283-290. PubMed ID: 28222447
[TBL] [Abstract][Full Text] [Related]
13. High coexpression of both EGFR and IGF1R correlates with poor patient prognosis in resected non-small-cell lung cancer.
Gately K; Forde L; Cuffe S; Cummins R; Kay EW; Feuerhake F; O'Byrne KJ
Clin Lung Cancer; 2014 Jan; 15(1):58-66. PubMed ID: 24210543
[TBL] [Abstract][Full Text] [Related]
14. [Expression and clinical significance of apoptosis-related oncogenes in stage I-II non-small cell lung cancer].
Wang DF; Zeng CG; Lin YB; Hou JH; Zhu ZH
Ai Zheng; 2006 Mar; 25(3):359-62. PubMed ID: 16536995
[TBL] [Abstract][Full Text] [Related]
15. The expression of plakoglobin is a potential prognostic biomarker for patients with surgically resected lung adenocarcinoma.
He X; Zhou T; Yang G; Fang W; Li Z; Zhan J; Zhao Y; Cheng Z; Huang Y; Zhao H; Zhang L
Oncotarget; 2016 Mar; 7(12):15274-87. PubMed ID: 26933815
[TBL] [Abstract][Full Text] [Related]
16. Risk of recurrence in patients with surgically resected stage I non-small cell lung carcinoma: histopathologic and immunohistochemical analysis.
Poleri C; Morero JL; Nieva B; Vázquez MF; Rodríguez C; de Titto E; Rosenberg M
Chest; 2003 Jun; 123(6):1858-67. PubMed ID: 12796161
[TBL] [Abstract][Full Text] [Related]
17. Predictive survival markers in patients with surgically resected non-small cell lung carcinoma.
Moldvay J; Scheid P; Wild P; Nabil K; Siat J; Borrelly J; Marie B; Farré G; Labib T; Pottier G; Sesboüé R; Bronner C; Vignaud JM; Martinet Y; Martinet N
Clin Cancer Res; 2000 Mar; 6(3):1125-34. PubMed ID: 10741743
[TBL] [Abstract][Full Text] [Related]
18. Prognostic significance of CD151 overexpression in non-small cell lung cancer.
Kwon MJ; Seo J; Kim YJ; Kwon MJ; Choi JY; Kim TE; Lee DH; Park S; Shin YK; Han J; Choi YL
Lung Cancer; 2013 Jul; 81(1):109-16. PubMed ID: 23570797
[TBL] [Abstract][Full Text] [Related]
19. Prognostic significance of K-ras, p53, bcl-2, PCNA, CD34 in radically resected non-small cell lung cancers.
Grossi F; Loprevite M; Chiaramondia M; Ceppa P; Pera C; Ratto GB; Serrano J; Ferrara GB; Costa R; Boni L; Ardizzoni A
Eur J Cancer; 2003 Jun; 39(9):1242-50. PubMed ID: 12763212
[TBL] [Abstract][Full Text] [Related]
20. Loss of Bad expression confers poor prognosis in non-small cell lung cancer.
Huang Y; Liu D; Chen B; Zeng J; Wang L; Zhang S; Mo X; Li W
Med Oncol; 2012 Sep; 29(3):1648-55. PubMed ID: 21918885
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
